These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23559238)

  • 1. Physiology. The perfect hypnotic?
    Mignot E
    Science; 2013 Apr; 340(6128):36-8. PubMed ID: 23559238
    [No Abstract]   [Full Text] [Related]  

  • 2. International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and pharmacology.
    Gotter AL; Webber AL; Coleman PJ; Renger JJ; Winrow CJ
    Pharmacol Rev; 2012 Jul; 64(3):389-420. PubMed ID: 22759794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putting addiction to bed.
    Soares C
    Sci Am; 2010 Jul; 303(1):23-4. PubMed ID: 20583657
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecule of the month. Almorexant.
    Drug News Perspect; 2009 May; 22(4):229. PubMed ID: 19536367
    [No Abstract]   [Full Text] [Related]  

  • 5. In the arms of Morpheus: Actelion keeps sleepers from waking.
    Wolfson W
    Chem Biol; 2009 Feb; 16(2):105-6. PubMed ID: 19245999
    [No Abstract]   [Full Text] [Related]  

  • 6. The hypocretin/orexin receptor: therapeutic prospective in sleep disorders.
    Nishino S
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1785-97. PubMed ID: 17970638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypocretin antagonists in insomnia treatment and beyond.
    Ruoff C; Cao M; Guilleminault C
    Curr Pharm Des; 2011; 17(15):1476-82. PubMed ID: 21476951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orexin receptor antagonists: medicinal chemistry and therapeutic potential.
    Roecker AJ; Coleman PJ
    Curr Top Med Chem; 2008; 8(11):977-87. PubMed ID: 18673167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Present status and future of hypnotic drug treatment for insomnia].
    Uchiyama M; Konno M
    Nihon Rinsho; 2012 Jul; 70(7):1241-51. PubMed ID: 22844812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To sleep, perchance to rest (in the daytime).
    Young O
    Lab Anim (NY); 2007 Apr; 36(4):8. PubMed ID: 17380133
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery of [(2R,5R)-5-{[(5-fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone (MK-6096): a dual orexin receptor antagonist with potent sleep-promoting properties.
    Coleman PJ; Schreier JD; Cox CD; Breslin MJ; Whitman DB; Bogusky MJ; McGaughey GB; Bednar RA; Lemaire W; Doran SM; Fox SV; Garson SL; Gotter AL; Harrell CM; Reiss DR; Cabalu TD; Cui D; Prueksaritanont T; Stevens J; Tannenbaum PL; Ball RG; Stellabott J; Young SD; Hartman GD; Winrow CJ; Renger JJ
    ChemMedChem; 2012 Mar; 7(3):415-24, 337. PubMed ID: 22307992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion of sleep by targeting the orexin system in rats, dogs and humans.
    Brisbare-Roch C; Dingemanse J; Koberstein R; Hoever P; Aissaoui H; Flores S; Mueller C; Nayler O; van Gerven J; de Haas SL; Hess P; Qiu C; Buchmann S; Scherz M; Weller T; Fischli W; Clozel M; Jenck F
    Nat Med; 2007 Feb; 13(2):150-5. PubMed ID: 17259994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orexin receptor antagonists: a review of promising compounds patented since 2006.
    Coleman PJ; Renger JJ
    Expert Opin Ther Pat; 2010 Mar; 20(3):307-24. PubMed ID: 20180618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 3,9-diazabicyclo[4.2.1]nonanes as potent dual orexin receptor antagonists with sleep-promoting activity in the rat.
    Coleman PJ; Schreier JD; Roecker AJ; Mercer SP; McGaughey GB; Cox CD; Hartman GD; Harrell CM; Reiss DR; Doran SM; Garson SL; Anderson WB; Tang C; Prueksaritanont T; Winrow CJ; Renger JJ
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4201-5. PubMed ID: 20610153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent and potential drugs for treatment of insomnia].
    Terao A; Miyamoto M
    Nihon Yakurigaku Zasshi; 2007 Jan; 129(1):35-41. PubMed ID: 17220574
    [No Abstract]   [Full Text] [Related]  

  • 16. Insomnia: chasing the dream.
    Crow JM
    Nature; 2013 May; 497(7450):S16-8. PubMed ID: 23698503
    [No Abstract]   [Full Text] [Related]  

  • 17. Where you least expect it: dopamine in the pons and modulation of sleep and REM-sleep.
    Keating GL; Rye DB
    Sleep; 2003 Nov; 26(7):788-9. PubMed ID: 14655908
    [No Abstract]   [Full Text] [Related]  

  • 18. Orexin receptor antagonists.
    Christopher JA
    Pharm Pat Anal; 2012 Jul; 1(3):329-46. PubMed ID: 24236845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to 'Promotion of sleep by targeting the orexin system in rats, dogs and humans'.
    Tafti M
    Nat Med; 2007 May; 13(5):525-6; author reply 526. PubMed ID: 17479088
    [No Abstract]   [Full Text] [Related]  

  • 20. Biomedical application of orexin/hypocretin receptor ligands in neuroscience.
    Boss C; Brisbare-Roch C; Jenck F
    J Med Chem; 2009 Feb; 52(4):891-903. PubMed ID: 19199652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.